HDAC inhibitors induce LIFR expression and promote a dormancy phenotype in breast cancer
Miranda E. Clements, Lauren Holtslander, Courtney Edwards, Vera M. Todd, Samuel Dooyema, Kennady K. Bullock, Kensey Bergdorf, Cynthia A. Zahnow, Roisín M. Connolly, Rachelle W. Johnson
Topics & Concepts
Breast cancerCancer researchBiologyLeukemia inhibitory factor receptorCancerHistone deacetylaseMetastatic breast cancerCarcinogenesisOncologyMetastasisInternal medicineImmunologyMedicineLeukemia inhibitory factorHistoneCytokineInterleukin 6GeneBiochemistryHistone Deacetylase Inhibitors ResearchProtein Degradation and InhibitorsUbiquitin and proteasome pathways